Xtant Medical Holdings, Inc. (XTNT)

NYSEAMERICAN: XTNT · USD

$0.28

+0.00 (+1.0%)· Recorded snapshot

Market cap	39.8M
Revenue (ttm)	109.5M
Net income (ttm)	-11.1M
EPS (ttm)	-$0.08
Shares out	140.3M
Volume	67,067
Beta	-0.20

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 109.5M
Net income (ttm): -11.1M
EPS (ttm): -$0.08
Market cap: 39.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-25.2

P25 n/aP50 n/aP75 n/a

ROIC-10.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All XTNT indicators

Market & fundamental data

Available fields

219

Groups with data

Currency

USD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001453593
Company name	Xtant Medical Holdings, Inc.
Country	United States
Country code	US
CUSIP number	98420P308
Earnings date	2026-11-09
Earnings time	bmo
Employees	151
Employees change	-81
Employees growth	-34.91%
Enterprise value	$55.9M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US98420P3082
Last 10-K release date	2026-03-31
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split date	2018-02-14
Last stock split type	Reverse
Market cap	$39.8M
Market cap category	Nano-Cap
Next earnings date	2026-11-09
Options	No
Price	$0.28
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	XTNT
U.S. state	Montana
Website	https://xtantmedical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-28.04%
EV/Sales	0.51x
FCF / EV yield	-1.25%
FCF yield	-1.77%
Forward EV/Sales	0.52x
Forward P/S	0.37x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/B ratio	0.98x
P/OCF ratio	69.11x
P/S ratio	0.36x
Price / tangible book value	1.17x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-5.02%
EBITDA margin	-1.34%
Gross margin	59.39%
Operating margin	-5.02%
Pretax margin	-8.44%
Profit margin	-10.17%
Profit per employee	$-73,755
Profitable years	1
Revenue per employee	$725,344
ROA	-3.75%
ROA (5Y)	-4.63%
ROCE	-11.06%
ROE	-25.16%
ROE (5Y)	-14.04%
ROIC	-10.17%
ROIC (5Y)	-12.58%
SBC / revenue	2.73%
Tax / revenue	1.73%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	-15.37%
Gross profit growth (Q)	-45.11%
Gross profit growth 3Y	18.39%
Gross profit growth 5Y	12.66%
Net income growth years	1
OCF growth	-62.03%
OCF growth 5Y	-20.43%
Revenue growth	-14.28%
Revenue growth (Q)	-34.96%
Revenue growth (QoQ)	10.28%
Revenue growth 10Y	2.89%
Revenue growth 3Y	17.27%
Revenue growth 5Y	14.54%
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-1.3M
Depreciation and amortization	$4M
EBIT	$-5.5M
EBITDA	$-1.5M
EPS	$-0.08
FCF per share	$-0.00
Financing cash flow	$-12M
Free cash flow	$-696,000
Free cash flow minus SBC	$-3.7M
Gross profit	$65M
Income taxes	$1.9M
Investing cash flow	$14.4M
Net borrowing	$-11.8M
Net cash flow	$3.2M
Net income	$-11.1M
Operating cash flow minus SBC	$-2.4M
Operating income	$-5.5M
Revenue	$109.5M
Stock-based compensation	$3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.73
Book value per share	$0.29
Debt / equity	0.65
Goodwill	$6.1M
Interest coverage	-1.99
Long-term assets	$14.9M
Long-term liabilities	$9.7M
Net cash (debt)	$-16.1M
Net cash / market cap	-40.98%
Net debt / equity	0.4
Piotroski F-Score	3
Property, plant and equipment	$8.4M
Shareholders' equity	$40M
Tangible book value	$33.7M
Tangible book value per share	$0.24
Total assets	$79.7M
Total cash	$9.9M
Total debt	$26M
Total liabilities	$39.7M
WACC	5.23%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.2
Current assets	$64.8M
Current liabilities	$30M
Current ratio	2.16
Inventory turnover	1.21
Net working capital	$41.3M
Quick ratio	0.98
Working capital	$34.8M
Working capital turnover	2.74

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.38%
Dividend yield	0%
Shareholder yield	-1.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-97.19%
10Y return CAGR	-30.03%
10Y total return	-97.19%
150-day SMA	$0.42
15Y price change	-99.92%
15Y return CAGR	-38.01%
15Y total return	-99.92%
1D price change	1.03%
1M price change	-24.49%
1M total return	-24.49%
1W price change	-4.16%
1W total return	-4.16%
1Y price change	-67.76%
1Y return CAGR	-67.79%
1Y total return	-67.76%
20-day SMA	$0.31
200-day SMA	$0.47
3M price change	-35.51%
3M total return	-35.51%
3Y price change	-73.97%
3Y return CAGR	-36.15%
3Y total return	-73.97%
50-day SMA	$0.33
50-day SMA vs 200-day SMA	50under200
52-week high	$0.95
52-week high date	2025-10-31
52-week low	$0.27
52-week low date	2026-08-12
5Y price change	-76.16%
5Y return CAGR	-24.93%
5Y total return	-76.16%
6M price change	-46.35%
6M total return	-46.35%
All-time high	$1,080.04
All-time high date	2011-01-03
All-time low	$0.27
All-time low date	2026-08-12
Average true range (ATR)	$0.02
Average volume	99.6K
Beta (1Y)	0.37
Beta (2Y)	0.8
Beta (5Y)	-0.2
Change from 52-week high	-70.14%
Change from 52-week low	5%
Change from all-time high	-99.97%
Change from all-time low	5%
Change from open	0%
Day's gap	1.03%
Dollar volume	$19,027
High price	$0.28
Low price	$0.28
Monthly RSI	37.56
Open price	$0.28
Premarket change	3.28%
Premarket close	$0.28
Premarket price	$0.29
Previous close	$0.28
Price vs 150-day SMA	-32.15%
Price vs 20-day SMA	-8.45%
Price vs 200-day SMA	-39.03%
Price vs 50-day SMA	-15.14%
Relative volume	0.68
RSI	37.82
Sharpe ratio	-1.49
Sharpe ratio (3Y)	-0.29
Sharpe ratio (5Y)	-0.1
Sortino ratio	-1.85
Sortino ratio (3Y)	-0.34
Sortino ratio (5Y)	-0.06
Volume	67.1K
Weekly RSI	34.12
YTD price change	-63.81%
YTD total return	-63.81%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54.2M
Float percentage	38.62%
Shares change (QoQ)	0.14%
Shares change (YoY)	1.38%
Shares held by insiders	12.63%
Shares held by institutions	13.52%
Shares outstanding	140.3M
Short % of float	0.26%
Short % of shares	0.1%
Short ratio	0.2 days

Deeper analysis on XTNT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this XTNT report

Is a complete XTNT research report available?

No complete published report is available for Xtant Medical Holdings, Inc. (XTNT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Xtant Medical Holdings, Inc. (XTNT)

Price

Financial snapshot

Fair-value bridge

Latest news · XTNT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XTNT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on XTNT

Frequently asked questions